Brief: Inmed Pharmaceuticals Inmed Shareholders Are Expected To Own Approximately 1.51% Of Combined Company
19/05/2026 13:41
May 19 (Reuters) - InMed Pharmaceuticals Inc INM.O: INMED PHARMACEUTICALS MENTARI THERAPEUTICS ANNOUNCE MERGER TO ADVANCE MIGRAINE PREVENTION THERAPIES INMED PHARMACEUTICALS: INMED SHAREHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 1.51% OF COMBINED COMPANY INMED PHARMACEUTICALS: POST DEAL, COMBINED COMPANY TO HAVE PRO FORMA EQUITY VALUE OF ABOUT US$421.4 MILLION (INCLUSIVE OF PRIVATE PLACEMENT) Source text: ID:nPn29Ny5Ha Further company coverage: INM.O ((Reuters.Briefs@thomsonreuters.com;))